Clinical Trial Update: Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 1 Hepatitis C Virus Infection Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of Seraprevir and Sofosbuvir in adults with chronic Hepatitis C genotype 1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Seraprevir (Seraprevir)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Ginkgopharma CO., LTD | Conditions: Hepatitis C Virus Infection | Phase 3 | Status: UNKNOWN